Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.510
+0.170 (7.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 231 | 135 | 94 | 18 | 10 | 42 | |
| Market Cap Growth | 229.55% | 43.39% | 422.07% | 73.39% | -75.50% | - | |
| Enterprise Value | 165 | 58 | 10 | -4 | -29 | 63 | |
| Last Close Price | 2.51 | 1.47 | 1.05 | 1.13 | 0.65 | 2.66 | |
| PB Ratio | 3.81 | 2.23 | 0.99 | 1.52 | 0.30 | 0.88 | |
| P/TBV Ratio | 3.81 | 2.23 | 0.99 | 1.52 | 0.30 | 0.88 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | 0.00 | - | |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -0.99 | -1.22 | -1.02 | -1.03 | |
| Net Debt / EBITDA Ratio | 1.66 | 1.66 | 3.15 | 0.58 | 2.38 | - | |
| Net Debt / FCF Ratio | 2.49 | 2.49 | 6.47 | 0.69 | 2.61 | 5.64 | |
| Quick Ratio | 8.23 | 8.23 | 34.36 | 3.45 | 11.07 | 16.36 | |
| Current Ratio | 8.52 | 8.52 | 35.62 | 3.83 | 11.80 | 16.90 | |
| Return on Equity (ROE) | -46.39% | -46.39% | -49.89% | -102.79% | -35.74% | -53.50% | |
| Return on Assets (ROA) | -29.79% | -29.79% | -32.76% | -58.01% | -20.84% | -17.96% | |
| Return on Capital Employed (ROCE) | -65.70% | -65.70% | -31.40% | -211.20% | -42.80% | -15.40% | |
| Earnings Yield | -15.66% | -26.75% | -28.37% | -132.83% | -142.58% | -24.63% | |
| FCF Yield | -11.46% | -19.56% | -15.46% | -116.66% | -130.57% | -20.72% | |
| Buyback Yield / Dilution | -62.94% | -62.94% | -265.88% | - | -463.44% | -37.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.